INN

Summit Hotel Properties, Inc. · NYSE

Sector Finance
Industry Real Estate Investment Trusts
Website reit.com
Employees(FY) 74
ISIN US8660821005

Performance

+1.49%

+11.8%

-0.89%

+20.78%

+6.42%

YTD

+9.35%

Profile

Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging properties with efficient operating models primarily in the upscale segment of the lodging industry. As of November 1, 2023, the Company's portfolio consisted of 101 assets, 57 of which are wholly owned, with a total of 15,035 guestrooms located in 24 states.

Advanced Technical Analysis

Technical Analysis of INN 2024-12-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 96, indicating robust upward momentum, while the Technical Score of 73 further supports this positive outlook; however, the Oscillators Score of 50 suggests a neutral stance, indicating potential consolidation or indecision in the short term. Overall, the combined score...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of INN

Stock Rank

Recent News & Updates

2024-12-19 16:33
Innocan Pharma Announces Private Placement of Units(CNW Group)
2024-12-17 19:00
INN: What does Argus have to say about INN?(Argus Research)
2024-12-12 16:01
Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024(CNW Group)
2024-12-10 19:00
INN: What does Argus have to say about INN?(Argus Research)
2024-12-10 17:00
Summit Hotel Properties Announces Pending Acquisition of Two-Hotel Portfolio for $96 Million Through GIC Joint Venture(PR Newswire)
2024-12-10 04:00
Summit Hotel Properties Announces Pending Acquisition of Two-Hotel Portfolio for $96 Million Through GIC Joint Venture(Prnewswire)
2024-12-03 19:00
INN: What does Argus have to say about INN?(Argus Research)
2024-11-26 19:00
INN: Rating decreased to a HOLD(Argus Research)
2024-11-26 16:01
Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs(CNW Group)
2024-11-20 16:01
Innocan Pharma Reports Third Quarter 2024 Financial Results(CNW Group)
2024-11-13 19:00
How To Put $100 In Your Retirement Fund Each Month With Summit Hotel Properties Stock(Yahoo Finance)
2024-11-12 19:00
INN: Rating increased to a BUY(Argus Research)
2024-11-11 16:01
Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand(CNW Group)
2024-11-06 02:12
Summit Hotel Properties Inc (INN) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...(GuruFocus.com)
2024-11-06 00:12
Q3 2024 Summit Hotel Properties Inc Earnings Call(Thomson Reuters StreetEvents)
2024-11-05 19:00
INN: Lowering target price to $6.00(Argus Research)
2024-11-04 18:05
Summit Hotel Properties (INN) Q3 FFO and Revenues Beat Estimates(Zacks)
2024-11-04 17:02
Summit Hotel Properties: Q3 Earnings Snapshot(Associated Press Finance)
2024-11-04 16:30
SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2024 RESULTS(PR Newswire)
2024-11-04 07:10
Summit Hotel Properties Inc (INN) Q3 2024 Earnings Report Preview: What To Expect(GuruFocus.com)
2024-11-04 03:30
SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2024 RESULTS(Prnewswire)
2024-10-31 21:06
Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q3 2024 Result(Yahoo Finance)
2024-10-24 17:00
SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2024 DIVIDENDS(PR Newswire)
2024-10-24 05:00
SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2024 DIVIDENDS(Prnewswire)
2024-10-20 21:30
Innocan Pharma to Present at the 2024 ThinkEquity Conference(Yahoo Finance)
2024-10-16 16:01
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience(CNW Group)
2024-10-11 16:01
Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs(CNW Group)
2024-10-10 08:50
Summit Hotel Properties (INN) Shows Fast-paced Momentum But Is Still a Bargain Stock(Zacks)
2024-10-09 16:01
Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide(CNW Group)
2024-10-08 20:00
INN: Rating decreased to a HOLD(Argus Research)

Page 1 of 8

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.